MedPath

Endari

These highlights do not include all the information needed to use ENDARI™ safely and effectively. See full prescribing information for ENDARI. ENDARI (L-glutamine oral powder ) Initial U.S. Approval: 2017

Approved
Approval ID

d5a783f4-12ef-4326-8faa-40018e45ba3b

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 19, 2022

Manufacturers
FDA

Emmaus Medical, Inc.

DUNS: 784073434

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Glutamine

PRODUCT DETAILS

NDC Product Code42457-420
Application NumberNDA208587
Marketing CategoryC73594
Route of AdministrationORAL
Effective DateOctober 27, 2020
Generic NameGlutamine

INGREDIENTS (1)

GlutamineActive
Quantity: 5 g in 1 1
Code: 0RH81L854J
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Endari - FDA Drug Approval Details